Implementation and Clinical Application of Digital Breast Tomosynthesis
Sarah M. Friedewald, MD
Division Chief of Breast and Women’s Imaging
Medical Director, Lynn Sage Comprehensive Breast Center
Northwestern Medicine/Prentice Women’s Hospital
Learning Objectives | At the conclusion of this presentation, the participant will be able to:
1. Review the main literature published on the benefits and effectiveness of Breast Tomosynthesis
2. Review the life span of Breast Tomosynthesis until present
3. Compare the effectiveness of Breast Tomosynthesis as it relates to breast density and a comparison to ultrasound
Target audience: Physicians who interpret breast screening images, as well as sonographers and technologists.
Release Date: 11/1/2022
Expiration Date: 12/1/2025
Credit: 1 AMA PRA Category 1 Credit™
1 Category A CE Credit
CONFLICT OF INTEREST DISCLOSURE
Sarah M. Friedewald, MD
Consultant: Hologic, IncPrinciple Investigator: Google
All of the relevant financial relationships for this faculty have been mitigated by peer review completed by peers with no relevant financial relationships to disclose.
None of the other program directors/planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
World Class CME designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Radiologic Technologists Credit has approved this activity as follows:
|Reference No.||Cat.||Activity Title||Start Date||Expires||Credit|
|NCZ02320014||A||Implementation and Clinical Application of Digital Breast Tomosynthesis||11/1/2022||12/1/2025||1
World Class CME relies on its CME faculty to provide program content that is evidence-based and free of commercial bias. Therefore, in accordance with ACCME standards, any faculty, program director, reviewer and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.
This activity is supported by an unrestricted educational grant from Hologic, Inc.
Instructions to Receive Credit:
After viewing the video, click on the “Take the Quiz” button and complete the post-activity quiz. After completing the quiz, fill out the evaluation form and submit. Your CME certificate will then be emailed to you.
ACR Statement on Breast Tomosynthesis November 24, 2014 www.acr.org
Boniface MM, et al. Value analysis of digital breast tomosynthesis for breast cancer screening in an commercially-insured US population. ClinicoOutcomes Res. 2015 Jan 12;7:53-63
Friedewald SM. Tomosynthesis: Practical Considerations. Radiol Clin North Am. 2017 May;55(3):493-502
Friedewald SM et al. Lesion localization using the scroll bar on tomosynthesis: Why doesn’t it always work? Clinical imaging 2018 Jan-Feb;47:57-64